These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35950286)

  • 1. Sarcopenia, healthy living, and mortality in patients with chronic liver diseases.
    Van Dongen C; Paik JM; Harring M; Younossi Y; Price JK; Kabbara K; Golabi P; Younossi ZM
    Hepatol Commun; 2022 Nov; 6(11):3140-3153. PubMed ID: 35950286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.).
    Paik JM; Eberly KE; Kabbara K; Harring M; Younossi Y; Henry L; Verma M; Younossi ZM
    Ann Hepatol; 2023; 28(4):101108. PubMed ID: 37088421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States.
    Kim D; Wijarnpreecha K; Sandhu KK; Cholankeril G; Ahmed A
    Liver Int; 2021 Aug; 41(8):1832-1840. PubMed ID: 33641244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
    Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
    Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver disease.
    Paik JM; Deshpande R; Golabi P; Younossi I; Henry L; Younossi ZM
    Aliment Pharmacol Ther; 2020 Jan; 51(2):291-304. PubMed ID: 31782543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease.
    Golabi P; Gerber L; Paik JM; Deshpande R; de Avila L; Younossi ZM
    JHEP Rep; 2020 Dec; 2(6):100171. PubMed ID: 32964202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Trends in American Heart Association Revised Life's Simple 7 Metrics Associated With Risk of Mortality Among US Adults.
    Han L; You D; Ma W; Astell-Burt T; Feng X; Duan S; Qi L
    JAMA Netw Open; 2019 Oct; 2(10):e1913131. PubMed ID: 31603489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia modifies the associations of nonalcoholic fatty liver disease with all-cause and cardiovascular mortality among older adults.
    Sun X; Liu Z; Chen F; Du T
    Sci Rep; 2021 Aug; 11(1):15647. PubMed ID: 34341404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk.
    Han E; Lee YH; Kim YD; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Nam HS; Heo JH; Kim SU
    Am J Gastroenterol; 2020 Apr; 115(4):584-595. PubMed ID: 32141917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey.
    Moon JH; Koo BK; Kim W
    J Cachexia Sarcopenia Muscle; 2021 Aug; 12(4):964-972. PubMed ID: 34080327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A healthy lifestyle, Life's Essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK Biobank.
    He P; Zhang Y; Ye Z; Li H; Liu M; Zhou C; Yang S; Gan X; Zhang Y; Qin X
    Metabolism; 2023 Sep; 146():155643. PubMed ID: 37380018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality.
    Kim D; Manikat R; Shaikh A; Cholankeril G; Ahmed A
    Eur J Clin Invest; 2024 Jan; 54(1):e14087. PubMed ID: 37638383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Income-to-Poverty Ratio on Long-Term Mortality of Persons with Chronic Liver Disease in the USA, 1999-2018.
    Nguyen BT; Nguyen VH; Le M; Henry L; Cheung R; Nguyen MH
    Dig Dis; 2024; 42(5):473-485. PubMed ID: 38885622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of lung function and chronic obstructive pulmonary disease with American Heart Association's Life's Simple 7 cardiovascular health metrics.
    Fan W; Lee H; Lee A; Kieu C; Wong ND
    Respir Med; 2017 Oct; 131():85-93. PubMed ID: 28947048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study.
    Han E; Chun HS; Lee YH; Lee JS; Lee HW; Kim BK; Park JY; Kim DY; Lee BW; Kang ES; Cha BS; Ahn SH; Kim SU
    J Gastroenterol Hepatol; 2023 Sep; 38(9):1598-1609. PubMed ID: 37321651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA.
    Wijarnpreecha K; Kim D; Raymond P; Scribani M; Ahmed A
    Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1121-1128. PubMed ID: 30888971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD) Is Associated With Advanced Fibrosis.
    Harring M; Golabi P; Paik JM; Shah D; Racila A; Cable R; Srishord M; Younossi ZM
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2876-2888.e5. PubMed ID: 36848980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the American Heart Association's "Life's simple 7" score in French-speaking adults from Québec.
    Harrison S; Couillard C; Robitaille J; Vohl MC; Bélanger M; Desroches S; Provencher V; Rabasa-Lhoret R; Bouchard L; Langlois MF; Houle J; Lemieux S; Lamarche B
    Nutr Metab Cardiovasc Dis; 2019 Jul; 29(7):684-691. PubMed ID: 31078363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C.
    Golabi P; Paik JM; Eberly K; de Avila L; Alqahtani SA; Younossi ZM
    Ann Hepatol; 2022; 27(1):100556. PubMed ID: 34800721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Heart Association's life simple 7 and the risk of atrial fibrillation in the PREDIMED study cohort.
    Díaz-Gutiérrez J; Martínez-González MÁ; Alonso A; Toledo E; Salas-Salvadó J; Sorlí JV; Ros E; Fitó M; Estruch R; Arós F; Fiol M; Lapetra J; Gómez-Gracia E; Serra-Majem L; Pintó X; Portolés O; Babio N; Castañer O; Ruiz-Canela M
    Nutr Metab Cardiovasc Dis; 2023 Jun; 33(6):1144-1148. PubMed ID: 36958970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.